This topic contains a solution. Click here to go to the answer

Author Question: The numerical scale that measures the depth of a coma is known as the ________ Coma Scale. A) ... (Read 148 times)

lak

  • Hero Member
  • *****
  • Posts: 546
The numerical scale that measures the depth of a coma is known as the ________ Coma Scale.
 
  A) Babinski
  B) Glasgow
  C) Romberg
  D) Huntington

Question 2

The Reed-Sternberg cell appears in a biopsy from which cancer?
 
  A) adenocarcinoma
  B) Hodgkin's lymphoma
  C) multiple myeloma
  D) chronic myelogenous leukemia



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tjayeee

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

B
Explanation: A) Babinski's sign is not related to a coma.
B) Correct
C) The Romberg test is not related to a coma.
D) Huntington's disease is not related to a coma.

Answer to Question 2

B
Explanation: A) Reed-Sternberg cells are not associated with adenocarcinoma.
B) Correct
C) Reed-Sternberg cells are not associated with multiple myeloma.
D) Reed-Sternberg cells are not associated with chronic myelogenous leukemia.




lak

  • Member
  • Posts: 546
Reply 2 on: Jun 27, 2018
Excellent


ashely1112

  • Member
  • Posts: 347
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library